{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:23:37Z","timestamp":1773285817742,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T00:00:00Z","timestamp":1578268800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Methadone maintenance treatment (MMT) has been proven to be effective in treating opioid dependence. In Vietnam, MMT services are provided primarily by public clinics, with only one private MMT clinic established in recent years. Assessing the preferences of patients for different MMT models is important in evaluating the feasibility of these models. This study measured the preferences of drug users enrolling in public and private MMT clinics in Vietnam and examines the related factors of these preferences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was performed on 395 participants at 3 methadone clinics in Nam Dinh. Data about the preferences for MMT models and sociodemographic characteristics of participants were collected. Exploratory factor analysis was employed to explore the construct validity of the questionnaire. The chi-square test and Mann-Whitney test were used for analyzing demographic characteristics and preferences of participants. Multivariate logistic regression identified factors associated with participants\u2019 preferences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Half the participants received MMT treatment in a private facility (49.4%). Two preference dimensions were defined as \u201cAvailability and convenience of service\u201d and \u201cCompetencies of clinic and health professionals\u201d. Self-employed patients were more likely to consider these two dimensions when choosing MMT models. Only 9.9% of participants chose \u201cPrivacy\u201d as one of the evaluation criteria for an MMT facility. Compared to public clinics, a statistically higher percentage of patients in the private clinic chose the attitudes of health workers as the reason for using MMT service (34.7% and 7.6% respectively). Mean score of satisfaction towards MMT services was 8.6 (SD = 1.0), and this score was statistically higher in a public facility, compared to the private facility (8.7 and 8.4 respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The study highlighted patterns of patient preferences towards MMT clinics. Compared to the public MMT model, the private MMT model may need to enhance their services to improve patient satisfaction.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-019-0355-x","type":"journal-article","created":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T19:03:05Z","timestamp":1578337385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Preferences for methadone clinics among drug users in Vietnam: a comparison between public and private models"],"prefix":"10.1186","volume":"17","author":[{"given":"Tuan Anh","family":"Le","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuan Anh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anh Duc","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuong Tat","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai Thanh","family":"Phan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giang Thu","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trang Huyen Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl A.","family":"Latkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus S. H.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger C. M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bach Xuan","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangbo","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melvyn W. B.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"355_CR1","first-page":"23","volume":"10","author":"G Herget","year":"2005","unstructured":"Herget G. Methadone and buprenorphine added to the WHO list of essential medicines. HIV AIDS Policy Law Rev. 2005;10:23\u20134.","journal-title":"HIV AIDS Policy Law Rev"},{"key":"355_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/09540121.2011.608420","volume":"24","author":"BX Tran","year":"2012","unstructured":"Tran BX, Ohinmaa A, Duong AT, Do NT, Nguyen LT, Mills S, Houston S, Jacobs P. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam. AIDS Care. 2012;24:283\u201390.","journal-title":"AIDS Care"},{"key":"355_CR3","unstructured":"World Health Organization. Proposal for the inclusion of methadone in the WHO model list of essential medicines. Geneva; 2004."},{"key":"355_CR4","doi-asserted-by":"publisher","first-page":"732484","DOI":"10.1155\/2012\/732484","volume":"2012","author":"TT Nguyen","year":"2012","unstructured":"Nguyen TT, Nguyen LT, Pham MD, Vu HH, Mulvey KP. Methadone maintenance therapy in Vietnam: an overview and scaling-up plan. Adv Prev Med. 2012;2012:732484.","journal-title":"Adv Prev Med"},{"key":"355_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12954-016-0091-4","volume":"13","author":"BX Tran","year":"2016","unstructured":"Tran BX, Nguyen LH, Nong VM, Nguyen CT, Phan HT, Latkin CA. Behavioral and quality-of-life outcomes in different service models for methadone maintenance treatment in Vietnam. Harm Reduct J. 2016;13:4.","journal-title":"Harm Reduct J"},{"key":"355_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12954-015-0063-0","volume":"12","author":"BX Tran","year":"2015","unstructured":"Tran BX, Nguyen LH, Phan HT, Nguyen LK, Latkin CA. Preference of methadone maintenance patients for the integrative and decentralized service delivery models in Vietnam. Harm Reduct J. 2015;12:29.","journal-title":"Harm Reduct J"},{"key":"355_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13011-017-0123-4","volume":"12","author":"VL Boggiano","year":"2017","unstructured":"Boggiano VL, Nguyen HLT, Nguyen LH, Tran TD, Van Nguyen H, Le HT, Le HQ, Hoang CD, Nguyen CT, Tran BX, et al. Sexual behaviors among methadone maintenance patients in a mountainous area in northern Vietnam. Subst Abuse Treat Prev Policy. 2017;12:39.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"355_CR8","unstructured":"Control VAoHA. Vietnam Administration of HIV\/AIDS Control, Methadone Mainternance Treatment Progress Report until March 2017. Hanoi; 2017."},{"key":"355_CR9","unstructured":"VAoHA. C. The annual review of HIV\/AIDS control and prevention in the first six months 2016 and action plan in the last six months in 2016. Hanoi; 2016."},{"key":"355_CR10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.drugpo.2016.01.017","volume":"31","author":"BX Tran","year":"2016","unstructured":"Tran BX, Phan HT, Nguyen LH, Nguyen CT, Nguyen AT, Le TN, Latkin CA. Economic vulnerability of methadone maintenance patients: implications for policies on co-payment services. Int J Drug Policy. 2016;31:131\u20137.","journal-title":"Int J Drug Policy"},{"key":"355_CR11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/09595239200185071","volume":"11","author":"JR Caplehorn","year":"1992","unstructured":"Caplehorn JR. A comparison of private and public methadone maintenance patients. Drug Alcohol Rev. 1992;11:43\u20139.","journal-title":"Drug Alcohol Rev"},{"key":"355_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/09595238780000591","volume":"6","author":"R Baldwin","year":"1987","unstructured":"Baldwin R. The cost of methadone maintenance programs: a comparison between public hospital clinics and private practitioner programs in New South Wales. Aust Drug Alcohol Rev. 1987;6:185\u201393.","journal-title":"Aust Drug Alcohol Rev"},{"key":"355_CR13","volume-title":"Performance measurement for health system improvement: experiences, challenges and prospects","author":"PC Smith","year":"2008","unstructured":"Smith PC, Mossialos E, Papanicolas I. Performance measurement for health system improvement: experiences, challenges and prospects. Copenhagen: World Health Organization; 2008."},{"key":"355_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1177\/1359105307088142","volume":"13","author":"Z Zhiwei","year":"2008","unstructured":"Zhiwei Z, Gerstein DR, Friedmann PD. Patient satisfaction and sustained outcomes of drug abuse treatment. J Health Psychol. 2008;13:388\u2013400.","journal-title":"J Health Psychol"},{"key":"355_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0740-5472(97)00181-5","volume":"14","author":"DD Simpson","year":"1997","unstructured":"Simpson DD, Joe GW, Rowan-Szal GA, Greener JM. Drug abuse treatment process components that improve retention. J Subst Abuse Treat. 1997;14:565\u201372.","journal-title":"J Subst Abuse Treat"},{"key":"355_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/00952991003736371","volume":"36","author":"SM Kelly","year":"2010","unstructured":"Kelly SM, O'Grady KE, Brown BS, Mitchell SG, Schwartz RP. The role of patient satisfaction in methadone treatment. Am J Drug Alcohol Abuse. 2010;36:150\u20134.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"355_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1300\/J069v16n01_06","volume":"16","author":"M Herman","year":"1997","unstructured":"Herman M, Gourevitch MN. Integrating primary care and methadone maintenance treatment: implementation issues. J Addict Dis. 1997;16:91\u2013102.","journal-title":"J Addict Dis"},{"key":"355_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1089\/apc.2013.0179","volume":"28","author":"ML Drainoni","year":"2014","unstructured":"Drainoni ML, Farrell C, Sorensen-Alawad A, Palmisano JN, Chaisson C, Walley AY. Patient perspectives of an integrated program of medical care and substance use treatment. AIDS Patient Care STDS. 2014;28:71\u201381.","journal-title":"AIDS Patient Care STDS"},{"key":"355_CR19","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/j.drugpo.2013.07.007","volume":"24","author":"BX Tran","year":"2013","unstructured":"Tran BX, Nguyen LT. Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV\/AIDS. Int J Drug Policy. 2013;24:e105\u201310.","journal-title":"Int J Drug Policy"},{"key":"355_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/tmi.12032","volume":"18","author":"BX Tran","year":"2013","unstructured":"Tran BX, Duong AT, Nguyen LT, Hwang J, Nguyen BT, Nguyen QT, Nong VM, Vu PX, Ohinmaa A. Financial burden of health care for HIV\/AIDS patients in Vietnam. Trop Med Int Health. 2013;18:212\u20138.","journal-title":"Trop Med Int Health"},{"key":"355_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2471\/BLT.12.115147","volume":"91","author":"BX Tran","year":"2013","unstructured":"Tran BX. Willingness to pay for methadone maintenance treatment in Vietnamese epicentres of injection-drug-driven HIV infection. Bull World Health Organ. 2013;91:475\u201382.","journal-title":"Bull World Health Organ"},{"key":"355_CR22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1360-0443.2007.02053.x","volume":"103","author":"TM Hammett","year":"2008","unstructured":"Hammett TM, Wu Z, Duc TT, Stephens D, Sullivan S, Liu W, Chen Y, Ngu D, Des Jarlais DC. \u2018Social evils\u2019 and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam. Addiction. 2008;103:137\u201345.","journal-title":"Addiction"},{"key":"355_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1468-1293.2003.00130.x","volume":"4","author":"S Clarke","year":"2003","unstructured":"Clarke S, Delamere S, McCullough L, Hopkins S, Bergin C, Mulcahy F. Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Med. 2003;4:33\u20137.","journal-title":"HIV Med"},{"key":"355_CR24","doi-asserted-by":"crossref","unstructured":"Van Nguyen H, Nguyen HLT, Mai HT, Le HQ, Tran BX, Hoang CD, Le HT, Nguyen CT, Tran TD, Latkin CA, Vu TMT. Stigmatization among methadone maintenance treatment patients in mountainous areas in northern Vietnam. Harm Reduc J. 2017;14.","DOI":"10.1186\/s12954-016-0127-9"},{"key":"355_CR25","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/dar.12589","volume":"37","author":"CW Lan","year":"2018","unstructured":"Lan CW, Lin C, Thanh DC, Li L. Drug-related stigma and access to care among people who inject drugs in Vietnam. Drug Alcohol Rev. 2018;37:333\u20139.","journal-title":"Drug Alcohol Rev"},{"key":"355_CR26","doi-asserted-by":"publisher","first-page":"e016153","DOI":"10.1136\/bmjopen-2017-016153","volume":"7","author":"VM Nong","year":"2017","unstructured":"Nong VM, Boggiano VL, Nguyen LHT, Nguyen CT, Nguyen LH, Xuan Bach T, Nguyen HV, Hoang CD, Latkin CA, Vu MTT. Ability to join the workforce and work productivity among drug users under methadone maintenance treatment in a mountainous area of Northern Vietnam: a cross-sectional study. BMJ Open. 2017;7:e016153.","journal-title":"BMJ Open"},{"key":"355_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12954-015-0075-9","volume":"12","author":"TV Hoang","year":"2015","unstructured":"Hoang TV, Ha TT, Hoang TM, Nhu NT, Quoc NC, Tam N, Mills S. Impact of a methadone maintenance therapy pilot in Vietnam and its role in a scaled-up response. Harm Reduct J. 2015;12:39.","journal-title":"Harm Reduct J"},{"key":"355_CR28","doi-asserted-by":"publisher","first-page":"e0142644","DOI":"10.1371\/journal.pone.0142644","volume":"10","author":"BX Tran","year":"2015","unstructured":"Tran BX, Nguyen LH, Phan HT, Latkin CA. Patient satisfaction with methadone maintenance treatment in Vietnam: a comparison of different integrative-service delivery models. PLoS One. 2015;10:e0142644.","journal-title":"PLoS One"},{"key":"355_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1477-7517-9-26","volume":"9","author":"M Jardine","year":"2012","unstructured":"Jardine M, Thi Nguyen VA, Khuat TH. Case study: methadone maintenance treatment in Hanoi, Vietnam. Harm Reduct J. 2012;9:26.","journal-title":"Harm Reduct J"},{"key":"355_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/07359680802125923","volume":"24","author":"B Hogan","year":"2007","unstructured":"Hogan B, Hershey L, Ritchey S. A case study using a patient satisfaction survey to improve the delivery and effectiveness of drug addiction treatment services: marketing implications and organizational impact. Health Mark Q. 2007;24:93\u2013106.","journal-title":"Health Mark Q"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0355-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-019-0355-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0355-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:34:02Z","timestamp":1609806842000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-019-0355-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1186\/s12954-019-0355-x","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,6]]},"assertion":[{"value":"29 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and granted ethics approval by the Institutional Review Board of National Institute of Hygiene and Epidemiology.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}